Literature DB >> 7195645

Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance.

B J Maron, W C Roberts.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7195645     DOI： 10.1016/0002-8703(81)90419-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  9 in total

1.  Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.

Authors:  M B Perryman; Q T Yu; A J Marian; A Mares; G Czernuszewicz; J Ifegwu; R Hill; R Roberts
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 2.  Myocardial disorganisation in hypertrophic cardiomyopathy. Another point of view.

Authors:  B J Maron
Journal:  Br Heart J       Date:  1983-07

3.  The current status of myocardial disarray in hypertrophic cardiomyopathy.

Authors:  M J Davies
Journal:  Br Heart J       Date:  1984-04

Review 4.  Myocardial disarray. A critical review.

Authors:  A E Becker; G Caruso
Journal:  Br Heart J       Date:  1982-06

5.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

6.  Left ventricular endomyocardial biopsy findings in patients with essential hypertension and hypertrophic cardiomyopathy with special reference to the incidence of bizarre myocardial hypertrophy with disorganization and biopsy score.

Authors:  S Nunoda; A Genda; M Sekiguchi; R Takeda
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

7.  Restrictive cardiomyopathy in children. Ultrastructural findings.

Authors:  M Toussaint; C Planche; E Villain; J Kachaner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

8.  Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Laura-Ann McGill; Tevfik F Ismail; Sonia Nielles-Vallespin; Pedro Ferreira; Andrew D Scott; Michael Roughton; Philip J Kilner; S Yen Ho; Karen P McCarthy; Peter D Gatehouse; Ranil de Silva; Peter Speier; Thorsten Feiweier; Choukkri Mekkaoui; David E Sosnovik; Sanjay K Prasad; David N Firmin; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2012-12-24       Impact factor: 5.364

9.  Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.

Authors:  Michelle S Parvatiyar; Jamie L Marshall; Reginald T Nguyen; Maria C Jordan; Vanitra A Richardson; Kenneth P Roos; Rachelle H Crosbie-Watson
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.